Table 3.
Clinical characteristics and EUS-TA results of nonmalignant lesions.
| Variables | Total n = 108 |
No malignancy n = 28 |
Other than no malignancy n = 80 |
P |
|---|---|---|---|---|
| Median age (range),a y | 63 (29–86) | 63 (30–79) | 61 (29–86) | 0.93 |
| Male sex, n (%) | 59 (54.6) | 13 (46.4) | 46 (57.5) | 0.29 |
| Median tumor size (range), mm | 8 (2.5–10) | 7.45 (2.5–9.8) | 8 (2.5–10) | 0.49 |
| Tumor location, n (%) | 0.069 | |||
| Pancreatic head | 34 (31.5) | 13 (46.4) | 21 (25.9) | |
| Pancreatic body or tail | 74 (68.5) | 15 (53.6) | 59 (74.1) | |
| Needle type, n (%) | 0.77 | |||
| EUS-FNA | 63 (58.3) | 17 (60.7) | 46 (57.5) | |
| EUS-FNB | 45 (41.7) | 11 (39.3) | 34 (42.5) | |
| Needle size, n (%) | 0.35 | |||
| 19-Gauge or 22-gauge | 102 (94.4) | 26 (92.9) | 76 (95) | |
| 25-Gauge | 6 (5.6) | 2 (7.1) | 4 (5) | |
| Mean no. of passes for EUS-TA (IQR) | 3 (2–4) | 3.9 (2–4) | 3.1 (2–4) | 0.86 |
a Age at which EUS-TA was performed.
EUS-FNA/FNB: EUS fine-needle aspiration/biopsy; EUS-TA: EUS tissue acquisition; IQR: Interquartile range.